Observation on the Curative Effect of Acupuncture At Sensitized Points on Gallbladder Meridian in the Treatment of Neck Type Cervical Spondylopathy

Launched by LICHAORAN · Feb 22, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how acupuncture can help people with Neck Type Cervical Spondylopathy, a condition that causes pain and stiffness in the neck. Researchers want to see how acupuncture affects certain points along the gallbladder meridian, which is a pathway used in traditional Chinese medicine. By observing the effects of acupuncture, the goal is to improve how doctors diagnose and treat this condition.

To participate in the trial, individuals must be between 18 and 65 years old and have been diagnosed with Neck Type Cervical Spondylopathy. They should have moderate pain, rated between 4 and 6 on a simple scale from 0 to 10. Participants will need to provide informed consent and be willing to follow the study requirements. It's important to note that those with other serious health conditions, recent neck treatments, or certain mental health issues will not be eligible for this study. If you qualify and take part, you can expect to receive acupuncture treatment and contribute to valuable research that could help others with similar neck problems in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Meeting the diagnostic criteria of Neck Type Cervical Spondylopathy.
• • Age 18 to 65 years old gender is not limited.
• • Clear awareness good compliance willing to cooperate with the study and accept the experimental arrangement.
• • Physical examination may or may not be accompanied by positive signs of the musculoskeletal system (including limited motor function local tender points etc.).
• • The visual analogue Scale (VAS) score was more than 3 points and less than 7 points (ranging from 0 to 10 points).
• • Informed consent and sign informed consent.
• Exclusion Criteria:
• • It does not meet the diagnostic criteria and inclusion criteria of cervical spondylosis.
• • Under 18 years of age or over 65 years of age;
• • 2 weeks before the start of the experiment the relevant treatment of the disease or the use of relevant therapeutic drugs;
• • Patients with other types of cervical spondylosis (cervical radiculopathy vertebral artery type cervical spondylosis cervical myelopathy sympathetic cervical spondylosis) or with other serious organic diseases and patients with neck and shoulder pain caused by non-neck diseases;
• • Patients with cardiovascular and cerebrovascular liver kidney digestive system blood system and other serious life-threatening primary diseases or suffering from hemorrhagic diseases or skin diseases or pregnant or lactating women or have a history of cardiac pacemaker implantation;
• • Previous history of neck surgery or neck fracture;
• • Persons with confusion mental disorder or cognitive impairment;
• • The skin at the test site has scars redness swelling heat and pain that affect the test result.